We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Controversy of Intraperitoneal Hyperthermic Chemotherapy for Ovarian Cancer.
- Authors
ALECU, Lucian; TULIN, Adrian; SLAVU, Iulian; ORLOV-SLAVU, Cristina; SOCEA, Bogdan; NITIPIR, Cornelia
- Abstract
Although the standard treatment for ovarian carcinoma with peritoneal metastases is systemic chemotherapy alone or systemic chemotherapy with debulking surgery, a new technique gains more ground: a combination of hipertermic intraperitoneal chemotherapy (HIPEC) and optimal cytoreduction surgery. The proof is mounting regarding the benefits of HIPEC for patients with metastatic ovarian carcinoma but it still lacks a standard protocol of use. It has increased costs, and incomplete data regarding its safety. Due to these reasons, it is still considered an alternative treatment. Our study aimed to evaluate the published literature regarding this technique from the point of view of safety and efficacy when compared with the standard of care treatment.
- Subjects
CYTOREDUCTIVE surgery; HYPERTHERMIC intraperitoneal chemotherapy; CANCER chemotherapy; OVARIAN cancer; DRUG efficacy; AUTHORSHIP
- Publication
Medicina Moderna, 2020, Vol 27, Issue 4, p261
- ISSN
1223-0472
- Publication type
Article
- DOI
10.31689/rmm.2020.27.4.261